E.U. Drug Agency Recommends Dengue Vaccine For Approval As Research Shows Public Trust In Vaccines Low In Philippines After Dengvaxia Scandal

Associated Press: E.U. drug agency urges approval for dengue vaccine
“Europe’s drug regulator has recommended approving the first vaccine for dengue despite concerns about the vaccine’s wide use and a lawsuit in the Philippines alleging that it was linked to three deaths. The European Medicines Agency said Friday it had adopted a ‘positive opinion’ of French pharmaceutical company Sanofi’s Dengvaxia. The vaccine is the world’s first against dengue, which sickens about 96 million people annually…” (10/19).

VOA News: Public Trust in Vaccines Plummets After Philippines Dengue Crisis
“The ability to fight future pandemics could be at risk following a plunge in public confidence in vaccines in the Philippines, according to a report from the London School of Hygiene & Tropical Medicine. … The researchers measured the loss in public trust through their ongoing Global Vaccine Confidence Index. In 2015, 93 percent of Philippine respondents strongly agreed that vaccines were important. This year, that figure has fallen to just 32 percent, while only one in five people now believes vaccines are safe…” (Ridgwell, 10/21).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.